Skip to main content

Table 1 Participants descriptive statistics

From: Experiences of patients who developed oral mucositis during solid neoplasms treatment: a Ugandan qualitative study

  IDIs FGDs
Age   
Gender Female 8 15
Male 5 13
Cancer diagnosis Breast cancer 8 4
Chorio carcinoma   5
Kaposi’s Sarcoma 2 1
Ovarian Carcinoma   2
Cervical Carcinoma   2
Oesophageal carcinoma   2
Colorectal carcinoma 1 1
Pancreatic carcinoma   1
Small cell lung carcinoma 1 1
Nasopahrgeal carcinoma   1
Sinonaso carcinoma 2 1
Osteosarcoma   2
Rhabdosarcoma   1
Fibrosarcoma   4
Chemotherapy Cyclophosphamide, Adriamycin
5 fluoro-uracil (CAF)
8 4
Etoposide, Methotrexate, Actinomycin D, Cyclophosphamide Vincristine (EMACO)   5
Bleomycin and Vinicristine (BV) 2 1
5 fluoro-uracil, Leucovorin and Oxaliplatin (FolFox-6) 1  
Cisplatin and Etoposide 1  
Gemicitabine, Bleomycin, Etoposide and Cisplatin   1
Cisplatin and Etoposide 1  
Cisplatin and 5 Fluoro Uracil   2
Cisplatin and Paclitaxel   3
Doxorubicin, Vincristine, Cytarabine and Dounorubicin   1
Bleomycin, Vinicristine and Paclitaxel   2
Ifosphamide and Doxorubicin   1
Bleomycin, Etoposide and Cisplatin   1
Cisplatin and Doxorubicin   2
Oxaliplatin and Capecitabine   1
Vincristine,Adriamycin and Dacabazine   1
Gemicitabine and Docetaxel   1
Cyclophosphamide,Adriamycin, Vincristine and Prednisolone (CHOP) 1  
Paclitaxel   2